Abstract: Cancer is incredibly resilient, and a large part of its survival comes down to a superpower known as “metabolic flexibility.” Just like a hybrid

Abstract: When we think of a bank, we usually picture money and gold locked away securely inside a vault. In the world of modern medicine,

Abstract: Over the past 30 years, cancers diagnosed in adults under the age of 55 have risen sharply worldwide. Traditional DNA sequencing looks for inherited

Abstract: Sarcomas are rare, highly aggressive cancers that come in more than 80 different subtypes. Because every patient’s tumor is molecularly unique, standard treatments often

Abstract: Tear fluid has rapidly evolved from an obscure biological matrix into a highly prized, minimally invasive source of complex biomarkers. Driven by advancements in

Abstract: The intersection of industrial computing and high-throughput cellular biology has reached a critical inflection point. Greenstone Biosciences has announced a strategic collaboration with Intel

Abstract: The frontier of precision medicine is shifting from what our genes say to how our environments talk to our genes. Backed by a £16

Abstract: The intersection of microbiome health and cancer treatment has taken a major step forward with the Royal Veterinary College (RVC) launching Europe’s first dedicated

Abstract: The high cost, complex infrastructure, and strict temperature requirements of cryopreservation remain significant bottlenecks for biobanks worldwide. To address these challenges, researchers from the

Abstract: The role of biobanking is undergoing a radical shift as it converges with artificial intelligence. Traditionally seen as static repositories, biobanks are now evolving